The effect of Gencydo® injections on hayfever symptoms: A therapeutic causality report

Journal of Alternative and Complementary Medicine

Volumn 11, Issue 5, 2005, Pages 863-869

  Baars, Erik W ^a   De Bruin, Anja ^a  

^a LOUIS BOLK INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; HOMEOPATHIC AGENT; UNCLASSIFIED DRUG; ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; GENCYDO; PLANT EXTRACT;

ADOLESCENT; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GENCYDO; GENERAL PRACTITIONER; GRASS POLLEN; HAY FEVER; HUMAN; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; TREATMENT OUTCOME; CLINICAL TRIAL; DRUG EFFECT; INTRANASAL DRUG ADMINISTRATION; MIDDLE AGED; MUCOCILIARY CLEARANCE; NOSE MUCOSA;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AGED; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOCILIARY CLEARANCE; NASAL MUCOSA; PLANT EXTRACTS; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 28444441563     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2005.11.863     Document Type: Article

References (13)

1. De Bruin A, Baars E. Use of Gencydo nose spray in practice [in Dutch]. Internal Memorandum, Louis Bolk Instituut, the Netherlands, 2000.
2. Kiene H. Single-case causality assessment as a basis for clinical judgement. Altern Ther 1998;4:41-47.
3. Kiene H. Complementary methodology in clinical research. Cognition-based medicine [in German]. Berlin, Heidelberg, New York: Springer-Verlag, 2001.
4. Brooks CD, Karl KJ, Francom SF. Oral methylprednisolone acetate (Medrol tablets) for seasonal rhinitis: Examination of dose and symptom response. J Clin Pharmacol 1993;33:816-822.
5. Wilson AM, Sims EJ, Orr LC, et al. Effects of topical corticosteriod and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis. Ann Allergy Asthma Immnunol 2001;87:344-349.
6. Evans M. Prospective outcome study on prescribing anthroposophical medicines. Rundbrief Medizinische Section Goetheanum 1997;22:2-3.
7. Leids University Medical Centre (LUMC): Online document at: www.lumc.nl/1070/patientenzorg/Pollen%20informatie%20 Dienst/pollenstart.html
8. Fernando Florido J, Gonzalez Delgado P, Saenz de San Pedro B, et al. High levels of Olea europaea pollen and relation with clinical findings. Int Arch Allergy Immunol 1999;119:133-137.
9. Kato M, Hattori T, Ikeda R, et al. Amount of pollen has an effect on the systemic and local level of soluble ICAM-1 in patients with seasonal allergic rhinitis. Allergy 1996;51:128-132.
10. Vidal C, Dopazo A, Aira MJ. Parietaria pollinosis in an Atlantic area: clinical and palynological data. J Invest Allergol Clin Immunol 2001;11:107-111.
11. Winther L, Mailing HJ, Moseholm L, Mosbech H. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. I. Efficacy estimated by a model reducing the bias of annual differences in pollen counts. Allergy 2000;55:818-826.
12. Wu LY, Steidle GM, Meador MA, et al. Effect of tree and grass pollens and fungal spores on spring allergic rhinitis: A comparative study. Ann Allergy Asthma Immunol 1999;83:137-143.
13. Hróbjartsson A, Gøtzsch PC. Is the placebo powerless? NEJM 2001;344:1594-1602.